SCHEMBL3128787

SCHEMBL3128787

O=C1NC(=S)C(=Cc2ccc(-c3ccccc3)o2)S1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 6/20 0.76
DUSP3 P51452 1/20 0.70
POLB P06746 4/20 0.70
ALDH1A1 P00352 3/20 0.70
MAPT P10636 3/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
RECQL P46063 2/20 0.70
MCL1 Q07820 2/20 0.70
LMNA P02545 2/20 0.70
HPGD P15428 1/20 0.70
MAPK1 P28482 1/20 0.70
HTT P42858 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
TDP1 Q9NUW8 2/20 0.63
KDM4E B2RXH2 1/20 0.63
ALPL P05186 1/20 0.63
ALPI P09923 1/20 0.63
GAA P10253 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3128780 1.00 PIK3CG (0.76) PIK3CGDUSP3POLBALDH1A1MAPT
SCHEMBL12004076 1.00 PIK3CG (0.76) PIK3CGDUSP3POLBALDH1A1MAPT
SCHEMBL1064036 0.86 PIK3CG (1.00) PIK3CGPOLBMEN1KMT2ATDP1
SCHEMBL4200323 0.86 PIK3CG (1.00) PIK3CGPOLBMEN1KMT2ATDP1
SCHEMBL1064039 0.86 PIK3CG (1.00) PIK3CGPOLBMEN1KMT2ATDP1
SCHEMBL1082136 0.84 PIK3CG (0.95) PIK3CGPOLBMEN1KMT2AIGF1R
SCHEMBL1082135 0.84 PIK3CG (0.95) PIK3CGPOLBMEN1KMT2AIGF1R
SCHEMBL3125785 0.82 PIK3CG (0.78) PIK3CGPOLBALDH1A1MAPTMEN1
SCHEMBL3366587 0.82 PIK3CG (0.78) PIK3CGPOLBALDH1A1MAPTMEN1
SCHEMBL3125789 0.82 PIK3CG (0.78) PIK3CGPOLBALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 PIK3CG 4355/4885DUSP3 3629/4885POLB 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.